MDCM
EXAS

Morgan Dempsey Capital Management’s Exact Sciences EXAS Stock Holding History

Morgan Dempsey Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-249
Closed -$25K – 123
2020
Q3 		$25K Sell
249
-472
-65% -$40.8K 0.01% 118
2020
Q2 		$63K Sell
721
-65
-8% -$5.19K 0.03% 75
2020
Q1 		$46K Sell
786
-16
-2% -$1.3K 0.02% 90
2019
Q4 		$74K Hold
802
– – 0.03% 109
2019
Q3 		$72K Buy
802
+532
+197% +$60.6K 0.03% 120
2019
Q2 		$32K Sell
270
-20
-7% -$2.02K 0.01% 139
2019
Q1 		$25K Hold
290
– – 0.01% 141
2018
Q4 		$18K Buy
+290
New +$19.9K 0.01% 153

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Morgan Dempsey Capital Management's EXAS Position: Q4 2020 in Review

Morgan Dempsey Capital Management sold out of Exact Sciences (EXAS) in Q4 2020, closing a stake of 249 shares — an estimated $25K sold.

Morgan Dempsey Capital Management first reported a position in EXAS in Q4 2018 and held it in 8 quarters. The position peaked at $74K in Q4 2019. 622 funds tracked by Wall St. Rank hold EXAS as of Q4 2020.

  • Morgan Dempsey Capital Management reported no remaining Exact Sciences position as of Q4 2020 after selling out during the quarter.
  • Morgan Dempsey Capital Management sold 249 Exact Sciences shares in Q4 2020, an estimated $25K.
  • Morgan Dempsey Capital Management first reported a position in Exact Sciences in Q4 2018 and held it in 8 quarters.
  • Morgan Dempsey Capital Management's Exact Sciences position peaked at $74K in Q4 2019.
  • 622 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2020.

Based on Morgan Dempsey Capital Management's 13F filing for Q4 2020, filed 10 Feb 2021.